肥胖疑似心肌缺血患者预测风险与实际风险的不一致
结果显示,尽管肥胖患者风险评分和医生感知风险更高,但阻塞性冠心病发生率更低,随访25个月内心血管不良结局更少,提示现有风险评估工具需考虑肥胖因素。
要点
- 肥胖患者风险评分和医生感知风险偏高,但阻塞性冠心病实际发生率更低。
- BMI≥35患者Diamond-Forrester概率每增10%,阻塞性CAD的校正OR仅1.2。
- 随访25个月,肥胖程度与复合临床终点呈持续负相关。
核心结论
- 肥胖患者虽被预测为更高风险,但实际阻塞性冠心病发生率和不良临床结局均低于预测。
- 现有风险评估工具和指南需纳入肥胖因素以纠正预测偏差。
研究设计与样本
- 采用Cox回归分析BMI与阻塞性冠心病及复合临床终点的关联,中位随访25个月。
主要发现
- BMI≥30 kg/m2者占48%,BMI≥35者占20%。
- 肥胖患者更年轻、女性比例更高、吸烟更少,但高血压、糖尿病、黑人和久坐比例更高。
- 合并CAD风险估计在中等BMI组最高,而医生基于临床印象的CAD可能性随BMI增加而递增。
- Diamond-Forrester概率每增加10%,BMI<35组阻塞性CAD的校正OR为1.5(95%CI 1.4-1.5),BMI≥35组仅1.2(95%CI 1.1-1.3),交互p<0.001。
- Framingham风险评分随BMI类别升高而增加,但肥胖程度与所有三个复合临床终点呈强而一致的负相关。
临床怎么用
- 对肥胖疑似冠心病患者,应认识到现有风险评分可能高估其阻塞性CAD风险。
- 评估肥胖患者时需结合临床实际,避免仅凭风险评分或BMI过度推断冠心病可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To test the relationship between increasing severity of obesity, calculated risk and observed outcomes. METHODS: Patients with symptoms suggestive of coronary artery disease (CAD) (n=10 003) were stratified according to body mass index (BMI). We compared risk factors, pooled risk scores and physicians' perception of risk. Cox regression tested the association between BMI and (1) presence of obstructive CAD and (2) composite clinical endpoints (death, cardiovascular death, unstable angina hospitalisation and myocardial infarction). RESULTS: BMI was ≥30 kg/m2 in 48% of patients and ≥35 in 20%. Increasingly obese patients were younger, female and non-smoking but with higher prevalence of hypertension, diabetes, black race and sedentary lifestyle. Pooled risk estimates of CAD were highest in those with mid-range BMI. In contrast, physicians' estimation of the likelihood of significant CAD based on clinical impression increased progressively with BMI. For a 10% increase in the Diamond-Forrester probability of CAD, the adjusted OR for obstructive CAD was 1.5 (95% CI 1.4 to 1.5) in patients with BMI <35, but only 1.2 (95% CI 1.1 to 1.3) in those with BMI ≥35 (interaction p<0.001). Framingham Risk Score increased across increasing BMI categories. However, there was a strong and consistent inverse relationship between degree of obesity and all three composite clinical endpoints over a median 25 months of follow-up. CONCLUSIONS: Despite perceptions of higher risk and higher risk scores, increasingly obese patients had obstructive CAD less frequently than predicted and had fewer adverse clinical outcomes. There is a need for risk assessment tools and guidelines that account for obesity. TRIAL REGISTRATION NUMBER: NCT01174550.
引用
- Litwin SE, Coles A, Hill CL, et al. Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia. Heart. 2019. PMID: 31601728. doi:10.1136/heartjnl-2018-314503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。